Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basu, S.
Right arrow Articles by Berne, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basu, S.
Right arrow Articles by Berne, C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 28:1371-1375, 2005
© 2005 by the American Diabetes Association, Inc.


Pathophysiology/Complications
Original Article

Type 1 Diabetes Is Associated With Increased Cyclooxygenase- and Cytokine-Mediated Inflammation

Samar Basu, MSC, PHD1, Anders Larsson, MD, PHD2, Johan Vessby, MD1, Bengt Vessby, MD, PHD1 and Christian Berne, MD, PHD3

1 Section of Geriatrics and Clinical Nutrition Research, Uppsala University, Uppsala, Sweden
2 Section of Clinical Chemistry, Uppsala University, Uppsala, Sweden
3 Section of Internal Medicine, Faculty of Medicine, Uppsala University, Uppsala, Sweden

Address correspondence and reprint requests to Samar Basu, PhD, Section of Geriatrics and Clinical Nutrition Research, Faculty of Medicine, Uppsala University, P.O. Box 609, SE-751 25 Uppsala, Sweden. E-mail: samar.basu{at}pubcare.uu.se

OBJECTIVE—The extent of involvement of cyclooxygenase (COX)-mediated inflammation in type 1 diabetes is unknown, and the association between the COX- and cytokine-mediated inflammatory responses in type 1 diabetes is not fully understood.

RESEARCH DESIGN AND METHODS—Plasma high-sensitivity C-reactive protein (CRP), 24-h urinary and plasma 15-keto-dihydro-prostaglandin F2{alpha} (a metabolite of prostaglandin F2{alpha} [PGF2{alpha}] and an indicator of COX-mediated inflammation), serum amyloid protein A (SAA), and interleukin (IL)-6 (indicators of inflammation) were measured in 38 subjects with type 1 diabetes and 41 healthy age- and sex-matched control subjects.

RESULTS—The inflammatory indicators (urinary 15-keto-dihydro-PGF2{alpha}, P < 0.01; IL-6, P < 0.04) were increased in men with diabetes. CRP and SAA did not show any significant difference between the diabetic and the control subjects. Urinary levels of 15-keto-dihydro-PGF2{alpha} correlated with the degree of glycemic control, HbA1c (r = 0.42, P < 0.0005). No correlation was found between the duration of diabetes and the inflammatory biomarkers or metabolic measurements.

CONCLUSIONS—These results suggest that an early low-grade inflammatory process reflected by elevated levels of PGF2{alpha} and IL-6 is involved in type 1 diabetes. Thus, both COX- and cytokine-mediated inflammatory pathways are significantly related to type 1 diabetes.

Abbreviations: COX, cyclooxygenase • CRP, C-reactive protein • IL, interleukin • PGF2{alpha}, prostaglandin F2{alpha} • SAA, serum amyloid A


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
E. C. Kaizer, C. L. Glaser, D. Chaussabel, J. Banchereau, V. Pascual, and P. C. White
Gene Expression in Peripheral Blood Mononuclear Cells from Children with Diabetes
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3705 - 3711.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. M. Ladeia, E. Stefanelli, C. Ladeia-Frota, A. Moreira, A. Hiltner, and L. Adan
Association Between Elevated Serum C-Reactive Protein and Triglyceride Levels in Young Subjects With Type 1 Diabetes
Diabetes Care, February 1, 2006; 29(2): 424 - 426.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.